PTCT

#2359
PTC Therapeutics, Inc. - Common Stock
73.8 5 USD
+3.94%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
73.85
73.85
年范围
44.17
87.50
日变化
+3.94%
每月变动
+13.98%
6个月变化
-11.23%
年变化
+50.99%
前一天收盘价
71.0 5
Open
73.8 5
最低价
73.8 5
High
73.8 5
交易量
158
展开完整图表 完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 612.58 M
  • Employee 991
  • Founded 1998
  • CEO Matthew B. Klein
  • Website www.ptcbio.com
  • Headquarter Delaware, United States
  • FIGI BBG000QT15P7
  • Industry 生物技术
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
9.76
市销率
3.88

PTC Therapeutics, Inc. - Common Stock

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.

新闻